Shares of Acadia Pharma (NASDAQ: ACAD) plunged Tuesday after the company reported after the close on Monday that its Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE